Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Eric Verdin

Dr. Verdin is the President and CEO of the Buck Institute for Research on aging and a Professor of Medicine at the University of California, San Francisco. He studies molecular metabolism and its effect on human aging and associated diseases, such as Alzheimer’s. Alongside his doctorate and research at the University of Liege and Harvard Medical School, he has published more than 400 academic papers, holds 15 patents, and stands among the top 1% of the most-cited scientists.

A Glenn Award winner and member of several scientific organizations, such as the American Association for the American Society for Clinical Investigation and the Association of American Physicians, Dr. Verdin has also served at advanced biotech companies. Namely – Acylin, Elixir, Calico (Google), Nokia, Sofinnova Ventures, Pfizer, J&J, etc.